Health Care: Drugs

Telik Inc. (TELK: NASDAQ)

$1.3799 0.0299 | 2.21%
04/21/14 - 09:30 AM ET
Company Profile
Price and Volume
Recent Price 1.35
52 Week High 2.15
52 Week Low 1.05
Avg. Daily Vol. (Mil) 0.05
Beta (3 year) -0.60
Share Related Items
Mkt Cap (Mil) 6.19
Shares Out (Mil) 4.58
Float (Mil) 4.57
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.30
Current Ratio 2.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 3.74
Price/Cash Flow -1.20
Per Share Data
Earnings -1.17
Sales 0.00
Book Value 0.36
Cash Flow -1.14
Business Summary
Telik, Inc., is a clinical-stage drug development company focused on discovering and developing small molecule drugs to treat cancer.
General Information
2100 Geng Road
Suite 102
Palo Alto, CA 94303
www.telik.com
Industry : Drugs
Sector: Health Care
Employees: 11
CEO: Dr. Michael M. Wick,M.D.
Short Interest
Current Month (Mil) 0.02
Previous Month (Mil) 0.02
Short Interest Ratio (Days) 0.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -200.40
Return on Investments -316.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with TELK

Latest TELK Headlines from TheStreet

More Financial News for TELK

Press Releases for TELK

See All Press Releases

Partner Headlines for TELK

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter